Free Trial

Boston Scientific (BSX) News Today

Boston Scientific logo
$101.08 -1.31 (-1.28%)
Closing price 10/24/2025 03:59 PM Eastern
Extended Trading
$101.10 +0.02 (+0.02%)
As of 10/24/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why Is Boston Scientific Down Today?

Boston Scientific Corporation (NYSE: BSX) — shares are trading lower today despite a string of bullish analyst actions and upbeat quarterly results. Recent Q3 beats, multiple price-target raises and heavy call-option buying have driven positive sentiment, but intraday profit-taking, technical signals and a board departure are likely weighing on the stock.

  • Positive Sentiment: Multiple brokers are raising targets / reiterating Buy ratings (Truist raised target to $130). Truist Raises Target
  • Positive Sentiment: UBS and other firms reiterated Buy ratings and bullish outlooks (UBS maintained Buy). Analyst support and raised targets provide continued buy-side conviction. UBS Maintains Buy
  • Positive Sentiment: Leerink/other sell‑side analysts bumped near- and multi‑year EPS forecasts after the quarter, implying stronger forward earnings power. Leerink Raises Estimates
  • Positive Sentiment: Q3 results were better than expected and management raised the 2025 sales forecast, driving upside momentum earlier in the session. Earnings Beat & Higher Forecast
  • Positive Sentiment: Unusual options activity — heavy call buying indicates speculative bullish positioning and potential near-term upside pressure. High Call Volume
  • Neutral Sentiment: Options‑market flow analysis shows elevated interest but mixed signals on expiration strikes and skew — useful for short-term traders, less so for long-term investors. Options Market Analysis
  • Neutral Sentiment: Longer-term pieces highlight M&A strategy and organic growth, reinforcing a constructive thesis but not an immediate price catalyst. M&A & Organic Growth
  • Negative Sentiment: Board turnover: John E. Sununu will not seek re‑election, a governance change that can create short-term uncertainty. Board Departure
  • Negative Sentiment: Technical/market‑structure caution: some coverage notes a “death cross” risk and recent choppy trading that can prompt short-term selling. Technical Warning

Bottom line for investors: fundamentals and analyst revisions are bullish, supported by an earnings beat and stronger forecasts, while short‑term option flows and technical/board developments explain today's pullback. If you own BSX, consider whether this is a buying opportunity given raised estimates and analyst conviction, or a chance to trim on near-term volatility.

Posted 1+ days agoAI Generated. May Contain Errors.

BSX Latest News

What the Options Market Tells Us About Boston Scientific
Equities Analysts Set Expectations for BSX FY2025 Earnings
John E. Sununu to Leave Boston Scientific Board
Death Cross Stock Chart Grim Reaper
Beware the Death Cross: 3 Stocks Triggering This Spooky Signal
The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal.
Boston Scientific (NYSE:BSX) Updates Q4 2025 Earnings Guidance
Boston Scientific (NYSE:BSX) Releases FY 2025 Earnings Guidance
Boston Scientific announces results for third quarter 2025
What to Expect from Boston Scientific's Earnings
Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSX Media Mentions By Week

BSX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BSX
News Sentiment

0.85

0.93

Average
Medical
News Sentiment

BSX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BSX Articles
This Week

72

44

BSX Articles
Average Week

Get the Latest News and Ratings for BSX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Boston Scientific and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NYSE:BSX) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners